Comment on: Favipiravir, an antiviral for COVID-19?

被引：2
|
作者：
Chachaima-Mar, Jorge [1 ,2 ]
Perez-Castilla, Jesus [3 ]
机构：
[1] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru
[2] REDECS, Red Eficacia Clin & Sanitaria, Lima, Peru
[3] Natl Univ St Anthony Abbot Cusco, Sch Med, Cuzco, Peru
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2021年 / 76卷 / 01期
关键词：
D O I：
10.1093/jac/dkaa378
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：279 / 280
页数：3
相关论文
共 50 条
  • [41] Severe sinus bradycardia associated with favipiravir in a COVID-19 patient
    Habib, Mhd Baraa
    Elshafei, Mohamed
    Rahhal, Alaa
    Mohamed, Mouhand F. H.
    CLINICAL CASE REPORTS, 2021, 9 (08):
  • [42] An economical and practical procedure of favipiravir synthesis for the treatment of Covid-19
    Hacer Karatas
    Essam Hamied Ahmed Hanashalshahaby
    Unal Catal
    Yasar Enes Butun
    Elif Kurt
    Sahin Gursel
    Adil Kaya
    Mustafa Guzel
    Chemical Papers, 2023, 77 : 1695 - 1702
  • [43] Effect of favipiravir and an anti-inflammatory strategy for COVID-19
    Hitoshi Yamamura
    Hiroshi Matsuura
    Junichiro Nakagawa
    Hiroshi Fukuoka
    Hisaya Domi
    Satoru Chujoh
    Critical Care, 24
  • [44] A favipiravir-induced angioedema and urticaria in a COVID-19 patient
    Ozturk, Figen Ergur
    Ozturk, Ayperi
    Ates, Hale
    ANTIVIRAL THERAPY, 2022, 27 (06)
  • [45] The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment
    Cinarka, Halit
    Gunluoglu, Gulsah
    Cortuk, Mustafa
    Yurt, Sibel
    Kiyik, Murat
    Kosar, Filiz
    Tanriverdi, Elif
    Arslan, Melih Akay
    Baydili, Kursad Nuri
    Koc, Aysu Sinem
    Altin, Sedat
    Cetinkaya, Erdogan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (04) : 1624 - 1630
  • [46] Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19
    Omeroglu, Seyda Kayhan
    Temel, Fehminaz
    Altun, Dilek
    Oztop, Burak
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (06) : 2827 - 2834
  • [47] Comparison of Liver Safety of Favipiravir and Hydroxychloroquine in COVID-19 Treatment
    Izci-Cetinkaya, Feyza
    Karagoz, Hatice
    Yildiz, Orhan
    KLIMIK JOURNAL, 2020, 33 (03) : 235 - 240
  • [48] Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19
    Ison, Michael G.
    Scheetz, Marc H.
    EBIOMEDICINE, 2021, 63
  • [49] Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options
    Sreekanth Reddy, Obireddy
    Lai, Wing-Fu
    CHEMBIOCHEM, 2021, 22 (06) : 939 - 948
  • [50] An economical and practical procedure of favipiravir synthesis for the treatment of Covid-19
    Karatas, Hacer
    Hanashalshahaby, Essam Hamied Ahmed
    Catal, Unal
    Butun, Yasar Enes
    Kurt, Elif
    Gursel, Sahin
    Kaya, Adil
    Guzel, Mustafa
    CHEMICAL PAPERS, 2023, 77 (03) : 1695 - 1702
12345